Summary
In vitro release testing of semisolid formulations is currently used as a QA tool to ensure batch-la-batch unifonruty. This article gives examples of several techniques and apparatuses thai could be employed in release testing of semisolid drug products. ~emistry of the crosslinking of gelatin is a compl ex phenomenon. the nature of whi ch is dependent on several factors. The present manuscript represents an attempt to answer some specific basic science issues. Two "stress" cond itions are commonly known in connection with gelatin capsules. The first condition is induced by exposure to formaldehyde. The second stress condition is created by exposing the gelatin capsules to hi g h moisture and elevated temperatures (Le ., stressed storage conditions). The adverse effect of prolonged storage on in vi tro disintegration and on subsequent drug release from gelatin capsules has long been known . Changes in in vitro dissolution due to exposure to high humidity have been observed in capsules containing chloramphenicol, tetracycline.
nitrofurantoin, and either water insoluble
or relatively water soluble agents. The principal concern is to detemline the effect of stressed conditions on the bioavai lability andlor the clinical efficacy of a drug from gelatin capsules or gelatin coated tablets. It has been shown recently that hard gelatin capsules tested in a dissolution Crosslinking Of Gelatin Capsules (continued from front cover) the same as in pre-stress condition, and is a reflection of the in-vivo behavior of the product.
Several examples exist in the literature that demonstrate that while tbe rate of the in vitro dissolution (in media containing no enzymes) of drugs from hard gelatin capsules was decreased under stressed storage condition, no differences in bioavailability of these drugs were observed in vivo.
These findings strongly suggest that dissolution studies with hard gelatin capsules should be conducted in two stages, one in a dissolution medium without enzymes and secondly. in dissolution media containing enzymes (pepsin at pH 1.2. or pancreatin at pH 7.2 representing gastric and intestinal media respectively). Testing for contamination with formaldehyde as well as low molecular weight aldehydes should be a standard part of excipient evaluation procedures.
